cytotoxic activity against hela Search Results


99
ATCC cytotoxic activity against hela
Cytotoxic Activity Against Hela, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/HeLa/pmc05325191-186-11-35
Average 99 stars, based on 1 article reviews
cytotoxic activity against hela - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC cytotoxicity against vero cell lines
Cytotoxicity Against Vero Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/Vero/10__56808_slash_3027___7922__1914-46-0-16
Average 99 stars, based on 1 article reviews
cytotoxicity against vero cell lines - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC cytotoxic effect against mda mb 468 breast cancer cell line
Cytotoxic Effect Against Mda Mb 468 Breast Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/MDA-MB-468/10__1039_slash_d0ra02688c-24-15-12
Average 99 stars, based on 1 article reviews
cytotoxic effect against mda mb 468 breast cancer cell line - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
JCRB Cell Bank hl-60 cells
Hl 60 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/hl+60+cells/10__3390_slash_molecules25194462-231-3-7
Average 90 stars, based on 1 article reviews
hl-60 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
ATCC cytotoxic activity against colorectal
Cytotoxic Activity Against Colorectal, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/HCT+116/pmc12573006-50-26-46
Average 99 stars, based on 1 article reviews
cytotoxic activity against colorectal - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

97
ATCC cytotoxic activity against hct 8
Cytotoxic Activity Against Hct 8, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/HCT-8/pm15497940-49-33-62
Average 97 stars, based on 1 article reviews
cytotoxic activity against hct 8 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology antibodies against sirt1
List of primer sequences used for qRT-PCR.
Antibodies Against Sirt1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/SIRT1+Antibody/pmc06556284-106-19-23
Average 96 stars, based on 1 article reviews
antibodies against sirt1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

99
ATCC significant cytotoxic activity against mcf 7 breast cancer cells
List of primer sequences used for qRT-PCR.
Significant Cytotoxic Activity Against Mcf 7 Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/MCF7/pmc12593040-265-6-37
Average 99 stars, based on 1 article reviews
significant cytotoxic activity against mcf 7 breast cancer cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC vitro cytotoxicity against mda mb 231 breast cancer cells
List of primer sequences used for qRT-PCR.
Vitro Cytotoxicity Against Mda Mb 231 Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/MDA-MB-231/pmc07407519-204-51-46
Average 99 stars, based on 1 article reviews
vitro cytotoxicity against mda mb 231 breast cancer cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC cytotoxic activity against a549 atcc 185 cells
Cell viability and Cytotoxicity of AgNPs@chitosan and AgNPs@chitosan-NaF on normal lung fibroblast WI-38 cells (A,B) , and lung carcinoma epithelial <t>A549</t> ATCC-185 cells (C,D) for 24 h. The results were taken from replicated ( n = 3) (Mean ± SD).
Cytotoxic Activity Against A549 Atcc 185 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/A549/pmc11754292-156-47-51
Average 99 stars, based on 1 article reviews
cytotoxic activity against a549 atcc 185 cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC vitro cytotoxicity against normal human lung cell line mrc5
Cell viability and Cytotoxicity of AgNPs@chitosan and AgNPs@chitosan-NaF on normal lung fibroblast WI-38 cells (A,B) , and lung carcinoma epithelial <t>A549</t> ATCC-185 cells (C,D) for 24 h. The results were taken from replicated ( n = 3) (Mean ± SD).
Vitro Cytotoxicity Against Normal Human Lung Cell Line Mrc5, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/MRC-5/pmc06540956-146-111-120
Average 99 stars, based on 1 article reviews
vitro cytotoxicity against normal human lung cell line mrc5 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC cytotoxicity against human embryonic kidney hek cells
Cell viability and Cytotoxicity of AgNPs@chitosan and AgNPs@chitosan-NaF on normal lung fibroblast WI-38 cells (A,B) , and lung carcinoma epithelial <t>A549</t> ATCC-185 cells (C,D) for 24 h. The results were taken from replicated ( n = 3) (Mean ± SD).
Cytotoxicity Against Human Embryonic Kidney Hek Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cytotoxic+activity+against+hela/293T%3B+Embryonic+Kidney+Cells%3B+Human/pmc10795512-181-39-46
Average 99 stars, based on 1 article reviews
cytotoxicity against human embryonic kidney hek cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


List of primer sequences used for qRT-PCR.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

doi: 10.1155/2019/6492029

Figure Lengend Snippet: List of primer sequences used for qRT-PCR.

Article Snippet: The membranes were blocked with 5% skim milk for one hour at room temperature and were incubated with primary antibodies against SIRT1 (sc-74504, Santa Cruz), p53 acetylated on K382 (Ac-p53) (ab75754, Abcam), CDKN2A/p16 INK4a (ab108349, Abcam), p21 (ab109199, Abcam), FOXO3a (#2497, Cell Signaling), cyclin D1 (sc-8396, Santa Cruz), cyclin E (sc-481, Santa Cruz), eNOS (#9586, Cell Signaling), endothelial nitric oxide synthase (eNOS) phosphorylated on S1177 (p-eNOS) (#9571, Cell Signaling), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sc-25778 and sc-47724, Santa Cruz) at 4°C overnight.

Techniques:

Characterization of senescent EPCs: (a) passage 8 EPCs were considered young, and passage 18 EPCs were considered senescent. Young cells and senescent cells were cultured in medium, and SA- β -gal staining was performed. Representative images of SA- β -gal-stained young and senescent EPCs are shown. SA- β -gal-positive cells are stained a green color. Scale bars: 25 μ M and 5 μ M. (b) Quantification of SA- β -gal-positive cells from three replicates ( n = 3 per group). (c) Young and senescent EPCs were seeded in 96-well plates, and cell proliferation capacity was determined using the WST-8 assay. Absorbance was measured at 0, 12, 24, and 48 h at 450 nM wavelength ( n = 6 per group). (d) Young and senescent cells were seeded in the upper chamber of a Transwell® culture plate. After 6 h, migrated cells were stained and images were taken under a microscope at 100x magnification ( n = 3 wells per group). (e) Quantification of the number of migrated cells among young and senescent EPCs using ImageJ software. (f) For tube formation capacity, young and senescent EPCs were seeded in 96-well plates containing Matrigel®. After 6 h, representative images were taken under a microscope at 40x magnification ( n = 3 per group). Scale bars: 25 μ M. (g) Quantification of the tube length of branches per field in μ M and (h) number of tube branches per field using ImageJ software ( n = 3). (i) Cells were harvested, and total cell lysates were subjected to western blot analysis for protein expression of SIRT1, acetylated p53, p16 INK4a , and p21 for young and senescent EPCs. ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. young EPCs by unpaired Student's t -test.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

doi: 10.1155/2019/6492029

Figure Lengend Snippet: Characterization of senescent EPCs: (a) passage 8 EPCs were considered young, and passage 18 EPCs were considered senescent. Young cells and senescent cells were cultured in medium, and SA- β -gal staining was performed. Representative images of SA- β -gal-stained young and senescent EPCs are shown. SA- β -gal-positive cells are stained a green color. Scale bars: 25 μ M and 5 μ M. (b) Quantification of SA- β -gal-positive cells from three replicates ( n = 3 per group). (c) Young and senescent EPCs were seeded in 96-well plates, and cell proliferation capacity was determined using the WST-8 assay. Absorbance was measured at 0, 12, 24, and 48 h at 450 nM wavelength ( n = 6 per group). (d) Young and senescent cells were seeded in the upper chamber of a Transwell® culture plate. After 6 h, migrated cells were stained and images were taken under a microscope at 100x magnification ( n = 3 wells per group). (e) Quantification of the number of migrated cells among young and senescent EPCs using ImageJ software. (f) For tube formation capacity, young and senescent EPCs were seeded in 96-well plates containing Matrigel®. After 6 h, representative images were taken under a microscope at 40x magnification ( n = 3 per group). Scale bars: 25 μ M. (g) Quantification of the tube length of branches per field in μ M and (h) number of tube branches per field using ImageJ software ( n = 3). (i) Cells were harvested, and total cell lysates were subjected to western blot analysis for protein expression of SIRT1, acetylated p53, p16 INK4a , and p21 for young and senescent EPCs. ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. young EPCs by unpaired Student's t -test.

Article Snippet: The membranes were blocked with 5% skim milk for one hour at room temperature and were incubated with primary antibodies against SIRT1 (sc-74504, Santa Cruz), p53 acetylated on K382 (Ac-p53) (ab75754, Abcam), CDKN2A/p16 INK4a (ab108349, Abcam), p21 (ab109199, Abcam), FOXO3a (#2497, Cell Signaling), cyclin D1 (sc-8396, Santa Cruz), cyclin E (sc-481, Santa Cruz), eNOS (#9586, Cell Signaling), endothelial nitric oxide synthase (eNOS) phosphorylated on S1177 (p-eNOS) (#9571, Cell Signaling), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sc-25778 and sc-47724, Santa Cruz) at 4°C overnight.

Techniques: Cell Culture, Staining, Microscopy, Software, Western Blot, Expressing

SIRT1 deacetylase activity of MHY2233: (a) schematic diagram to show isolation of EPCs from the human umbilical cord blood, treatment with drugs, and other basic experimental designs. (b) Chemical structure of MHY2233. (c) EPCs were seeded in 96-well plates and treated with different concentrations of MHY2233 for 24 h ( n = 6 per group). Cytotoxicity assay of MHY2233 at different concentrations was determined using WST-8 assay ( n = 6 per group). (d) Relative mRNA levels of SIRT1 to SIRT7 in young and senescent EPCs were evaluated by qRT-PCR ( n = 3 per group). (e) Relative mRNA expression of SIRT1 to SIRT7 in senescent EPCs treated with DMSO and MHY2233 ( n = 3 per group). (f) SIRT1 deacetylase activity was performed using a commercially available kit. Measurement of SIRT1 deacetylase activity of MHY2233 along with positive and negative controls ( n = 6 per group). ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. DMSO (control) and indicated groups by a one-way ANOVA test.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

doi: 10.1155/2019/6492029

Figure Lengend Snippet: SIRT1 deacetylase activity of MHY2233: (a) schematic diagram to show isolation of EPCs from the human umbilical cord blood, treatment with drugs, and other basic experimental designs. (b) Chemical structure of MHY2233. (c) EPCs were seeded in 96-well plates and treated with different concentrations of MHY2233 for 24 h ( n = 6 per group). Cytotoxicity assay of MHY2233 at different concentrations was determined using WST-8 assay ( n = 6 per group). (d) Relative mRNA levels of SIRT1 to SIRT7 in young and senescent EPCs were evaluated by qRT-PCR ( n = 3 per group). (e) Relative mRNA expression of SIRT1 to SIRT7 in senescent EPCs treated with DMSO and MHY2233 ( n = 3 per group). (f) SIRT1 deacetylase activity was performed using a commercially available kit. Measurement of SIRT1 deacetylase activity of MHY2233 along with positive and negative controls ( n = 6 per group). ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. DMSO (control) and indicated groups by a one-way ANOVA test.

Article Snippet: The membranes were blocked with 5% skim milk for one hour at room temperature and were incubated with primary antibodies against SIRT1 (sc-74504, Santa Cruz), p53 acetylated on K382 (Ac-p53) (ab75754, Abcam), CDKN2A/p16 INK4a (ab108349, Abcam), p21 (ab109199, Abcam), FOXO3a (#2497, Cell Signaling), cyclin D1 (sc-8396, Santa Cruz), cyclin E (sc-481, Santa Cruz), eNOS (#9586, Cell Signaling), endothelial nitric oxide synthase (eNOS) phosphorylated on S1177 (p-eNOS) (#9571, Cell Signaling), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sc-25778 and sc-47724, Santa Cruz) at 4°C overnight.

Techniques: Histone Deacetylase Assay, Activity Assay, Isolation, Cytotoxicity Assay, Quantitative RT-PCR, Expressing, Control

Roles of MHY2233 in SIRT1 signaling and rescue of replicative senescence in EPCs: (a) EPCs were cultured with DMSO or MHY2233 (10 nM, 100 nM, or 1 μ M) for replicative senescence, and SA- β -gal staining was performed. Representative images of SA- β -gal stain in senescent EPCs. Cells stained green are SA- β -gal-positive cells. (b) Quantification of SA- β -gal-positive cells ( n = 3 per group). (c) Cells were harvested, and total cell lysates were used in western blot analysis for protein expression of SIRT1 in senescent EPCs upon treatment with different concentrations of MHY2233. (d) After chronic treatment of senescent EPCs with DMSO, 10 nM MHY2233, 100 nM resveratrol, or 100 nM EX527, mRNA and total protein were isolated. Measurement of relative mRNA levels of SIRT1, (e) p16, (f) p21, and (g) p53 was analyzed using qRT-PCR ( n = 3 per group). (h) Whole cell lysates were subjected to western blot analysis for determining protein levels of FOXO3a, SIRT1, acetylated p53, p16 INK4a , and p21 in senescent EPCs. ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. DMSO (control) by a one-way ANOVA test.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

doi: 10.1155/2019/6492029

Figure Lengend Snippet: Roles of MHY2233 in SIRT1 signaling and rescue of replicative senescence in EPCs: (a) EPCs were cultured with DMSO or MHY2233 (10 nM, 100 nM, or 1 μ M) for replicative senescence, and SA- β -gal staining was performed. Representative images of SA- β -gal stain in senescent EPCs. Cells stained green are SA- β -gal-positive cells. (b) Quantification of SA- β -gal-positive cells ( n = 3 per group). (c) Cells were harvested, and total cell lysates were used in western blot analysis for protein expression of SIRT1 in senescent EPCs upon treatment with different concentrations of MHY2233. (d) After chronic treatment of senescent EPCs with DMSO, 10 nM MHY2233, 100 nM resveratrol, or 100 nM EX527, mRNA and total protein were isolated. Measurement of relative mRNA levels of SIRT1, (e) p16, (f) p21, and (g) p53 was analyzed using qRT-PCR ( n = 3 per group). (h) Whole cell lysates were subjected to western blot analysis for determining protein levels of FOXO3a, SIRT1, acetylated p53, p16 INK4a , and p21 in senescent EPCs. ∗ p < 0.05, ∗∗ p < 0.005, and ∗∗∗ p < 0.0005 vs. DMSO (control) by a one-way ANOVA test.

Article Snippet: The membranes were blocked with 5% skim milk for one hour at room temperature and were incubated with primary antibodies against SIRT1 (sc-74504, Santa Cruz), p53 acetylated on K382 (Ac-p53) (ab75754, Abcam), CDKN2A/p16 INK4a (ab108349, Abcam), p21 (ab109199, Abcam), FOXO3a (#2497, Cell Signaling), cyclin D1 (sc-8396, Santa Cruz), cyclin E (sc-481, Santa Cruz), eNOS (#9586, Cell Signaling), endothelial nitric oxide synthase (eNOS) phosphorylated on S1177 (p-eNOS) (#9571, Cell Signaling), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sc-25778 and sc-47724, Santa Cruz) at 4°C overnight.

Techniques: Cell Culture, Staining, Western Blot, Expressing, Isolation, Quantitative RT-PCR, Control

Possible working model of MHY2233 in preventing senescence in EPCs: possible mechanism of MHY2233 to prevent vascular senescence in EPCs. MHY2233 increases SIRT1 activity and, upon aging or stress, increases the activity of FOXO3a, which translocates into the nucleus and upregulates the expression of SIRT1. SIRT1 increases the activity of eNOS and reduces the ROS levels by producing nitric oxide. Similarly, SIRT1 downregulates the SASPs and p16 ink4a and reduces EPC senescence. Moreover, SIRT1 activity deacetylates p53 and downregulates the expression of p21, thereby reducing EPC senescence.

Journal: Oxidative Medicine and Cellular Longevity

Article Title: MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

doi: 10.1155/2019/6492029

Figure Lengend Snippet: Possible working model of MHY2233 in preventing senescence in EPCs: possible mechanism of MHY2233 to prevent vascular senescence in EPCs. MHY2233 increases SIRT1 activity and, upon aging or stress, increases the activity of FOXO3a, which translocates into the nucleus and upregulates the expression of SIRT1. SIRT1 increases the activity of eNOS and reduces the ROS levels by producing nitric oxide. Similarly, SIRT1 downregulates the SASPs and p16 ink4a and reduces EPC senescence. Moreover, SIRT1 activity deacetylates p53 and downregulates the expression of p21, thereby reducing EPC senescence.

Article Snippet: The membranes were blocked with 5% skim milk for one hour at room temperature and were incubated with primary antibodies against SIRT1 (sc-74504, Santa Cruz), p53 acetylated on K382 (Ac-p53) (ab75754, Abcam), CDKN2A/p16 INK4a (ab108349, Abcam), p21 (ab109199, Abcam), FOXO3a (#2497, Cell Signaling), cyclin D1 (sc-8396, Santa Cruz), cyclin E (sc-481, Santa Cruz), eNOS (#9586, Cell Signaling), endothelial nitric oxide synthase (eNOS) phosphorylated on S1177 (p-eNOS) (#9571, Cell Signaling), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sc-25778 and sc-47724, Santa Cruz) at 4°C overnight.

Techniques: Activity Assay, Expressing

Cell viability and Cytotoxicity of AgNPs@chitosan and AgNPs@chitosan-NaF on normal lung fibroblast WI-38 cells (A,B) , and lung carcinoma epithelial A549 ATCC-185 cells (C,D) for 24 h. The results were taken from replicated ( n = 3) (Mean ± SD).

Journal: Frontiers in Microbiology

Article Title: Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms

doi: 10.3389/fmicb.2024.1507274

Figure Lengend Snippet: Cell viability and Cytotoxicity of AgNPs@chitosan and AgNPs@chitosan-NaF on normal lung fibroblast WI-38 cells (A,B) , and lung carcinoma epithelial A549 ATCC-185 cells (C,D) for 24 h. The results were taken from replicated ( n = 3) (Mean ± SD).

Article Snippet: Further evaluation of the AgNPs@chitosan and AgNPs@chitosan-NaF showed the lowest level of cytotoxic activity against WI-38 cells against WI-38 cells at a concentration of less than 1,000 μg mL −1 (>59.25%),and at a concentration of less than 62.5 μg mL −1 (>59.10%), respectively ( , ), and cytotoxic activity against A549 ATCC-185 cells at a concentration of less than 1,000 μg mL −1 (>57.45%),and at a concentration of less than 15.62 μg mL −1 (>73.67%), respectively ( , ).

Techniques:

Morphological features on lung carcinoma epithelial A549 cells of (A) AgNPs@chitosan and (B) AgNPs@chitosan-NaF, the images were taken from the cells were treated with an average size of 10 nm for 24 h.

Journal: Frontiers in Microbiology

Article Title: Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms

doi: 10.3389/fmicb.2024.1507274

Figure Lengend Snippet: Morphological features on lung carcinoma epithelial A549 cells of (A) AgNPs@chitosan and (B) AgNPs@chitosan-NaF, the images were taken from the cells were treated with an average size of 10 nm for 24 h.

Article Snippet: Further evaluation of the AgNPs@chitosan and AgNPs@chitosan-NaF showed the lowest level of cytotoxic activity against WI-38 cells against WI-38 cells at a concentration of less than 1,000 μg mL −1 (>59.25%),and at a concentration of less than 62.5 μg mL −1 (>59.10%), respectively ( , ), and cytotoxic activity against A549 ATCC-185 cells at a concentration of less than 1,000 μg mL −1 (>57.45%),and at a concentration of less than 15.62 μg mL −1 (>73.67%), respectively ( , ).

Techniques: